Sign inJoin waitlistJoin the waitlist

Shifeng Mao

Chair, AHN Cancer Institute Urological Oncology Team · Allegheny Health Network Medical Education Consortium

Credentials: · · · · · ·

History

AHN Cancer Institute Urological Oncology Team Center · Allegheny Health Network Medical Education Consortium
Present
Urologic Oncology Department · Allegheny Health Network Medical Education Consortium
Present
Allegheny Health Network Medical Education Consortium
Present

Hematology and Medical Oncology
1990–1993
Internal Medicine
1987–1990
Doctor of Medicine
1983–1987

Research

The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells
Immunity · 2002 · 167 citations
Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias
Molecular and Cellular Biology · 1999 · First of 5 authors · 117 citations
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer
Journal of Clinical Oncology · 2021 · 117 citations

CP
Channing Paller
6 papers
Stephen Nimer
5 papers
EH
Elisabeth Heath
4 papers
MM
Mark Markowski
4 papers
Rodney Wegner
4 papers
SD
Samuel Denmeade
4 papers
AH
Arif Hussain
3 papers
CM
Catherine Marshall
3 papers
Emmanuel Antonarakis
3 papers
ME
Mario Eisenberger
3 papers
MC
Michael Carducci
3 papers
Rana McKay
3 papers · 2 as a resident

Clinical trials

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2033
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2039